In a recent article in the New York Times, researchers take a closer look at the growing concerns surrounding the labeling, and mislabeling, in the herbal supplement industry.
The article cites a study, published in BMC Medicine, in which a group of Canadian researchers used DNA bar-code testing to determine exactly what was in 44 bottles of popular herbal supplements. It wasn’t always what the label claimed.
“They found that many were not what they claimed to be, and that pills labeled as popular herbs were often diluted — or replaced entirely — by cheap fillers like soybean, wheat and rice.”
“Of 44 herbal supplements tested, one-third showed outright substitution, meaning there was no trace of the plant advertised on the bottle — only another plant in its place.”
What is concerning is that not only do these fillers and substitutions diminish the purported health benefits of the supplements in question, they introduce potential health risks for the people who are unknowingly ingesting them. Many of the fillers could have harmful side effects and possibly deadly risks for people with allergies.
There is some debate as to the reliability of the bar-code testing used in the study, as well as suggestion that the problem is not as widespread as the published findings imply. But regardless of these debates, there’s no denying the lack of testing and regulation within the industry.
“Policing the supplement industry is a special challenge. The F.D.A. requires that companies test the products they sell to make sure that they are safe. But the system essentially operates on the honor code. Unlike prescription drugs, supplements are generally considered safe until proved otherwise.”
Similar concerns have been raised numerous times in the supplement industry. It is clear that there are companies that work toward higher standards, and there are fly-by-night operations that only care about making a quick profit. There have been discussions about how to better self-regulate the industry in order to weed out such unscrupulous companies and raise the overall safety standards, but for now, it is up to the individual supplement companies to ensure the safety of their products and inform their customers correctly about those products.
This is why Fertility Nutraceuticals established a rigorous, three-step quality control process, which includes testing at an independent laboratory. By having a third-party laboratory test all our products and verify their label claims, we ensure the purity and quality of the fertility supplements we offer to our customers.
Regardless of what’s happening elsewhere in the industry, when it comes to our labels, what you read is what you get.
High-quality fertility supplement supplier adds strong new product in order to offer additional options for women looking to conceive.
New York City, NY, March 13, 2013
Fertility Nutraceuticals, LLC, a leading supplier of men’s and women’s fertility supplement products, announced the release of their newest fertility product for women, OVOENERGEN™. OVOENERGEN™ is a mega-dose nutritional supplement of pharmaceutical-grade coenzyme Q10 (CoQ10), developed in consultation with Dr. Robert Casper, Senior Investigator at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital in Toronto, Canada, the leading fertility expert and researcher of CoQ10 in women. OVOENERGEN™ CoQ10 is specifically designed to enhance female fertility by improving overall egg quality.
The CoQ10 in OVOENERGEN™ is a vitamin-like substance that acts as an antioxidant found throughout the body. CoQ10 has been used for a long time in male fertility context, but its use in women trying to conceive has drawn attention only recently. Dr. Casper’s preliminary study using 1000 mg daily of CoQ10 supplementation has shown its promising ability to support healthy egg development in the ovary. OVOENERGEN™ CoQ10 has been developed to replicate this experience.
Every package of OVOENERGEN™ contains four sheets of 21 soft gels, to be taken three times a day, seven days a week (84 soft gels total). OVOENERGEN™ is competitively priced at $195 per month and delivers more than three times the amount of CoQ10 per serving as in most other CoQ10 supplements. OVOENERGEN™ is available now and can be purchased via the Fertility Nutraceuticals, LLC’s http://www.fertinatal.com/shop/.
In addition to OVOENERGEN™, Fertility Nutraceuticals, LLC has also released ANDROENERGEN™ for men. ANDROENERGEN™ is a fertility supplement designed to support healthy sperm development.
About Fertility Nutraceuticals, LLC:
Fertility Nutraceuticals, LLC is a young company exclusively dedicated to highest-quality nutritional supplements for fertility. FERTINATAL® DHEA supplement is the company’s flagship product, with OVOENERGEN™ and ANDROENERGEN™ offering additional options. For more information, visithttp://www.fertinatal.com.
Fertility Nutraceuticals, LLC Announces Release of ANDROENERGEN® CoQ10, New Male Fertility Supplement
High-quality fertility supplement supplier adds strong new product in order to offer additional options for men looking to have children.
New York, NY, March 13, 2013
Fertility Nutraceuticals, LLC, a leading supplier of men’s and women’s fertility supplement products, announced the release of their newest fertility product for men, ANDROENERGEN®. ANDROENERGEN® is a mega-dose nutritional supplement of pharmaceutical-grade coenzyme Q10 (CoQ10), developed in collaboration with leading fertility researchers of CoQ10. From serving size to oil-suspended delivery that ensures best absorption, ANDROENERGEN® is specifically designed toenhance male fertility through healthy sperm.
The CoQ10 in ANDROENERGEN® is a vitamin-like substance that acts as an antioxidant found throughout the body. In some studies, CoQ10 has been shown to protect mitochondria, the energy-producing elements within cells, from oxidative damage, while supplying it with much-needed metabolic energy. This encourages development of healthy sperm for men looking to support their fertility.
Every package of ANDROENERGEN® contains four sheets of 21 soft gels to be taken three times a day, seven days a week (84 soft gels total). ANDROENERGEN® is competitively priced at $195 per month and delivers more than three times the amount of CoQ10 found in most other CoQ10 supplements. ANDROENERGEN® is available now and can be purchased via the Fertility Nutraceuticals, LLC flagship online store.
In addition to ANDROENERGEN®, Fertility Nutraceuticals, LLC has also released OVOENERGEN® for women. OVOENERGEN® is a fertility supplement designed to increase the quality of female eggs through robust energy metabolism and protection from oxidative stress.
About Fertility Nutraceuticals, LLC:
Fertility Nutraceuticals, LLC is a young company exclusively dedicated to highest-quality nutritional supplements for fertility. FERTINATAL® DHEA supplement is the company’s flagship product, with OVOENERGEN® and ANDROENERGEN® offering additional options. For more information, visit http://www.fertinatal.com.
Fertility Nutraceuticals, LLC Launches FERTINATAL Micronized DHEA Supplement for Enhanced Female Fertility
The new FERTINATAL micronized DHEA supplement from Fertility Nutraceuticals, LLC utilizes the same type of DHEA shown in studies by CHR to enhance female fertility.
New York, NY, December 22, 2011
Fertility Nutraceuticals, LLC – a company specializing in nutritional supplements for women and female fertility enhancement – is announcing the launch of FERTINATAL™ micronized dehydroepiandrosterone (DHEA) supplement. The high-quality DHEA supplement is designed to augment female fertility.
Intrigued by anecdotal evidence received from one of their patients, physicians at New York’s Center for Human Reproduction (CHR) – a leading fertility and research center – initiated research on the relationship between DHEA supplementation and enhanced female fertility. Although research on the effects of DHEA is still limited, the published results of CHR’s studies are encouraging.
FERTINATAL™ was developed to offer the public exactly the same kind of DHEA utilized by CHR in the center’s research studies. The product features the highest quality control standards, including a triple-step testing process with batch-testing by independent laboratories. Furthermore, FERTINATAL™ is micronized to the same particle sizes as used in those studies. The product’s three-step testing process ensures that FERTINATAL™ delivers on its three promises: a plant-derived DHEA product of highest quality, micronized to appropriate sizes for good absorption.
FERTINATAL™ is the first DHEA supplement exclusively designed for women and female fertility enhancement. To improve convenience, it is uniquely packaged in individual blister sheets, each containing seven (7) rows of three (3) daily tablets, representing one week of the suggested supply of DHEA supplementation. Each box of FERTINATAL™ contains four of these blister sheets (a four-week supply). FERTINATAL™ is not intended for individuals under the age of 18, and potential side effects are described on the product’s packaging.
FERTINATAL™ will become available exclusively through Fertility Nutraceuticals, LLC in January 2012.
About Fertility Nutraceuticals, LLC
Fertility Nutraceuticals, LLC is a newly established company exclusively dedicated to nutritional supplements for women and enhanced female fertility. FERTINATAL™ DHEA supplement is the company’s first product, with as many as 2-3 additional products expected to arrive throughout 2012. For more information, visit http://www.fertinatal.com.